The FDA has released an updated safety review that links Actos use to an increased risk of bladder cancer. This warning was first made public in 2010, added to labels of pioglitazone-containing medicines in 2011, and was further confirmed through additional studies reviewed by the FDA in late 2016.
Topics: Health, Health News, Actos, Bladder Cancer, Actos Lawsuit, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Ryan Foster, Foster & Houston, Actos Attorney, Actos Lawyer, Actos Law
Actos, a drug prescribed to help control blood sugar levels in those with Type 2 diabetes, has been linked to a number of catastrophic health complications including bladder cancer. The FDA has announced that use of Actos for more than one year may be associated with an increased risk of bladder cancer and death.
Topics: Health, Health News, Actos, Bladder Cancer, Actos Lawsuit, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Ryan Foster, Foster & Houston
Takeda Pharmaceutical Co., the manufacturer of Actos, proposed $2.2 billion to settle thousands of lawsuits, according to Bloomberg. As of April 2015 more than 8,000 lawsuits had been filed against the diabetes medicine claiming hidden cancer risks.
Topics: Health, Actos, FDA, Actos Lawsuit, Diabetes, Diabetes Drug, The Law Offices of Foster & Houston, FANDHLAW, Ryan Foster, Foster & Houston, Diabetes Drug Lawsuit